Rothberg, Bonnie E Gould <br/><br/>
Nuclear to non-nuclear Pmel17/gp100 expression (HMB45 staining) as a discriminator between benign and malignant melanocytic lesions.  [electronic resource] 

 -  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc  Sep 2008 
 - 1121-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1530-0285 
<br/><br/><label>Standard No.: </label>10.1038/modpathol.2008.100  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antigens, Neoplasm--metabolism<br/>Biomarkers, Tumor--metabolism<br/>Cell Nucleus--metabolism<br/>Diagnosis, Differential<br/>Fluorescent Antibody Technique, Indirect<br/>Humans<br/>Image Processing, Computer-Assisted<br/>Immunoenzyme Techniques<br/>Melanoma--metabolism<br/>Melanoma-Specific Antigens<br/>Membrane Glycoproteins--immunology<br/>Neoplasm Proteins--metabolism<br/>Nevus, Pigmented--metabolism<br/>Skin Neoplasms--metabolism<br/>Tissue Array Analysis<br/>gp100 Melanoma Antigen